| Turner Syndrome (n = 57) | Controls (n = 36) | P value†| Turner Syndrome without CoA (n = 49) | Turner Syndrome with CoA (n = 8) | P value‡ |
---|---|---|---|---|---|---|
Age [years] | 46.1 ± 10.2 | 46.0 ± 12.9 | 0.9 | 45.9 ± 10.2 | 47.1 ± 10.3 | 0.8 |
Weight [kg] | 62.5 ± 14.6 | 71.2 ± 13.5 | 0.01 | 61.8 ± 14.3 | 66.9 ± 16.4 | 0.4 |
Height [cm] | 147.2 ± 6.7 | 169.3 ± 6.4 | < 0.001 | 147.0 ± 7.1 | 148.1 ± 3.8 | 0.7 |
Body Mass Index [kg/m2] | 28.9 ± 6.7 | 24.9 ± 4.6 | 0.001 | 28.6 ± 6.6 | 30.5 ± 7.3 | 0.5 |
Body Surface Area | 1.5 ± 0.2 | 1.8 ± 0.2 | < 0.001 | 1.5 ± 0.2 | 1.6 ± 0.2 | 0.4 |
24 h systolic Blood Pressure [mmHg]a | 117.9 ± 12.7 | 115.2 ± 10.7 | 0.3 | 117.5 ± 13.0 | 120.1 ± 11.6 | 0.6 |
24 h diastolic Blood Pressure [mmHg]a | 74.5 ± 10.2 | 71.7 ± 6.6 | 0.1 | 74.3 ± 9.9 | 75.3 ± 12.5 | 0.8 |
Day-time systolic Blood Pressure [mmHg]a | 123.4 ± 13.5 | 121.4 ± 10.6 | 0.5 | 122.8 ± 13.5 | 126.6 ± 14.2 | 0.5 |
Day-time diastolic Blood Pressure [mmHg]a | 78.6 ± 11.4 | 76.9 ± 6.5 | 0.4 | 78.3 ± 10.7 | 80.3 ± 15.1 | 0.7 |
Night-time systolic Blood Pressure [mmHg]a | 106.4 ± 11.9 | 103.3 ± 11.1 | 0.2 | 106.4 ± 12.6 | 106.4 ± 8.2 | 1 |
Night-time diastolic Blood Pressure [mmHg]a | 66.2 ± 8.6 | 61.5 ± 7.1 | 0.01 | 66.3 ± 8.7 | 65.6 ± 8.9 | 0.9 |
Systolic Blood pressure, Sphygmocor (right) | 121.3 ± 12.9 | 119.4 ± 13.8 | 0.5 | 120.7 ± 13.3 | 125.1 ± 10.0 | 0.4 |
Diastolic Blood pressure, Sphygmocor (right) | 77.6 ± 9.8 | 72.1 ± 8.8 | 0.007 | 77.3 ± 10.1 | 79.4 ± 8.8 | 0.6 |
Systolic Blood pressure, Sphygmocor (left) | 118.2 ± 13.8 | 118.4 ± 14.0 | 1.0 | 117.8 ± 14.3 | 120.6 ± 10.1 | 0.6 |
Diastolic Blood pressure, Sphygmocor (left) | 76.3 ± 9.4 | 71.3 ± 9.0 | 0.01 | 76.2 ± 9.4 | 77.1 ± 10.3 | 0.8 |
Low Density Lipids [mmol/L]b | 2.6 ± 0.8 | 2.6 ± 0.9 | 0.9 | 2.7 ± 0.8 | 2.6 ± 0.9 | 0.9 |
High Density Lipids [mmol/L]b | 1.8 ± 0.6 | 1.8 ± 0.5 | 0.8 | 1.8 ± 0.5 | 1.7 ± 0.7 | 0.9 |
Triglycerides [mmol/L]b | 1.1 ± 0.7 | 1.1 ± 1.0 | 0.8 | 1.1 ± 0.6 | 1.4 ± 0.9 | 0.2 |
HbA1C [mmol/mol]b | 36.0 [28.0–70.0] | 35.5 [26.0–48.0] | 0.2 | 36.0 [28.0–62.0] | 38.4 [31.0–70.0] | 0.3 |
Bicuspid aortic valvec | 19% (11/57) | 0% (0/36) | 0.006 | 12% (6/49) | 63% (5/8) | 0.005 |
Coarctation of the aortac | 14% (8/57) | 0% (0/36) | 0.02 | 0% (0/49) | 100% (8/8) | < 0.001 |
Elongated transverse aortac | 46% (26/57) | 0% (0/36) | < 0.001 | 43% (21/49) | 63% (5/8) | 0.3 |
Type 2 Diabetesc | 18% (10/57) | 0% (0/36) | 0.006 | 12% (6/49) | 50% (4/8) | 0.03 |
Statinsc | 16% (9/57) | 3% (1/36) | 0.08 | 14% (7/49) | 25% (2/8) | 0.4 |
Aspirinc | 5% (3/57) | 0% (0/36) | 0.3 | 6% (3/49) | 0% (0/8) | 0.6 |
Antihypertensivesc | 49% (28/57) | 14% (5/36) | < 0.001 | 49% (24/49) | 50% (4/8) | 0.6 |
Hormone replacement treatmentc | 72% (41/57) | 3% (1/36) | < 0.001 | 73% (36/49) | 63% (5/8) | 0.4 |